Dissolving Microneedles for Transdermal Drug Delivery

Show simple item record

dc.contributor.author Lee, Jeong Woo
dc.date.accessioned 2009-01-27T13:12:23Z
dc.date.available 2009-01-27T13:12:23Z
dc.date.issued 2008-10-22
dc.identifier.uri http://hdl.handle.net/1853/26724
dc.description 2008 Ziegler Award Winner, presented as a keynote address at the 2008 School of Chemical and Biomolecular Engineering Fourth Year Colloquium, Wednesday October 22, 2008.
dc.description Runtime: 27:57 minutes
dc.description.abstract Microfabrication technology has been adapted to produce micron- scale needles as a safer and painless alternative to hypodermic needle injection, especially for protein biotherapeutics and vaccines. This study presents a novel design that encapsulates sensitive biomolecules within microneedles that dissolve within the skin for bolus or sustained delivery and leave behind no biohazardous sharp medical waste. A novel fabrication process was developed based on casting a viscous aqueous solution during centrifugation to fill a micro-fabricated mold with biocompatible carboxymethylcellulose or amylopectin formulations. This process encapsulated sulforhodamine B, bovine serum albumin, and lysozyme as model drugs; lysozyme was shown to retain full enzymatic activity after encapsulation and to remain 96% active after storage for two months at room temperature. Microneedles were also shown to be strong enough to insert into human cadaver skin and then to dissolve within minutes. Bolus delivery was achieved by encapsulating model drug just within microneedle shafts. For the first time, sustained delivery over hours to days was achieved by encapsulating drug within the microneedle backing, which served as a controlled release drug reservoir that delivered drug by a combination of swelling the backing with interstitial fluid drawn out of the skin and drug diffusion into the skin via channels formed by dissolved microneedles. We conclude that dissolving microneedles can be designed to encapsulate sensitive biomolecules, insert into skin, and enable bolus or sustained release drug delivery. en
dc.format.extent 27:57 minutes
dc.language.iso en_US en
dc.publisher Georgia Institute of Technology en
dc.subject Microfabrication en
dc.subject Microneedles en
dc.subject Minimally invasive en
dc.subject Polysaccharide en
dc.subject Protein delivery en
dc.subject Transdermal drug delivery en
dc.title Dissolving Microneedles for Transdermal Drug Delivery en
dc.type Presentation en
dc.type Video
dc.contributor.corporatename Georgia Institute of Technology. School of Chemical and Biomolecular Engineering
dc.contributor.corporatename Emory University. Dept. of Biomedical Engineering
dc.contributor.corporatename Georgia Institute of Technology. Dept. of Biomedical Engineering


Files in this item

Files Size Format View Description
lee.mp4 77.94Mb MPEG-4 video View/ Open Download Video
lee_presentation.pptx 3.060Mb Microsoft PowerPoint View/ Open PowerPoint Presentation
lee_streaming.html 915bytes HTML View/ Open Streaming Video

This item appears in the following Collection(s)

Show simple item record